financetom
Business
financetom
/
Business
/
Procter & Gamble was the target of EU antitrust probe alongside Coca-Cola bottlers, Bloomberg reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Procter & Gamble was the target of EU antitrust probe alongside Coca-Cola bottlers, Bloomberg reports
Apr 10, 2025 5:50 AM

(Reuters) -Tide detergent maker Procter & Gamble ( PG ) has been identified as the subject of an EU antitrust regulators' investigation initiated last month that had also targeted Coca-Cola bottlers, Bloomberg reported on Thursday citing people familiar with the matter.

The European Commission had conducted inspections at the premises of companies active in the non-alcoholic drinks sector and had also quizzed an unidentified personal care company in March over concerns of possible curbs on the trade of goods across Europe and carving up markets.

Companies risk fines of as much as 10% of their global annual revenues if found guilty of breaching EU antitrust rules against cartels and abuse of market power.

EU officials have sent over a questionnaire to P&G and are collecting evidence from competitors and customers, the Bloomberg report said. No formal allegations have been made against Procter & Gamble ( PG ).

The European Commission and Procter & Gamble ( PG ) did not immediately respond to Reuters request for comment.

Reuters had identified Coca-Cola bottlers as the target of EU antitrust regulators, citing a person with direct knowledge of the matter.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Context Therapeutics Acquires Phase 1-Ready T Cell Engager CT-95
BRIEF-Context Therapeutics Acquires Phase 1-Ready T Cell Engager CT-95
Jul 10, 2024
July 10 (Reuters) - Context Therapeutics Inc ( CNTX ): * CONTEXT THERAPEUTICS ACQUIRES PHASE 1-READY T CELL ENGAGER CT-95 * CONTEXT THERAPEUTICS ( CNTX ) - ACQUISITION EXPANDS CONTEXT PIPELINE WITH SECOND CLINICAL-STAGE T CELL ENGAGER FOR SOLID TUMORS * CONTEXT THERAPEUTICS ( CNTX ) - CT-95 IS ON TRACK FOR PHASE 1 INITIATION IN Q1 OF 2025 *...
BRIEF-Carlyle Completes Tender Offer For KFC Japan
BRIEF-Carlyle Completes Tender Offer For KFC Japan
Jul 10, 2024
July 10 (Reuters) - Carlyle Group Inc ( CG ): * CARLYLE COMPLETES TENDER OFFER FOR KFC JAPAN * CARLYLE GROUP ( CG ) : WILL PRIVATIZE KFC JAPAN AND OWN 100% OF THE COMPANY BY LATE SEPTEMBER 2024 Source text for Eikon: Further company coverage: ...
Vista Outdoor's Revelyst Sells Fiber Energy Products
Vista Outdoor's Revelyst Sells Fiber Energy Products
Jul 10, 2024
07:49 AM EDT, 07/10/2024 (MT Newswires) -- Vista Outdoor's ( VSTO ) Revelyst unit said Wednesday that it has sold Fiber Energy Products, a wood pellet manufacturer, to Lignetics. Financial terms of the transaction were not disclosed. The company said the sale is part of its strategy to adjust its portfolio, concentrating on its top brands and most profitable areas...
Wishpond Obtains TSXV Consent for Normal Course Issuer Bid
Wishpond Obtains TSXV Consent for Normal Course Issuer Bid
Jul 10, 2024
07:49 AM EDT, 07/10/2024 (MT Newswires) -- Wishpond Technologies ( WPNDF ) , a provider of marketing-focused online business services, said Wednesday that it received approval from the TSX Venture Exchange for a normal course issuer bid. From July 15 through July 14, 2025, the company can buy up to 2.7 million shares, 5% of the total 54.2 million shares...
Copyright 2023-2025 - www.financetom.com All Rights Reserved